Skip to main content
. 2012 Mar 19;3:33. doi: 10.3389/fgene.2012.00033

Table A4.

Odds ratios (OR) and 95% CIs for the main effect association between variants in ATIC, SHMT2, and SLC46A1 and ovarian carcinoma among 1,575 Caucasian subjects (Phase 1), Mayo Clinic, and Duke University.

Gene/SNP rsID Homozygous major allele (referent)
Heterozygous
Homozygous minor allele
P value (2 df) Ordinal (per minor allele)
Cases Controls Cases Controls OR (95%CI)a Cases Controls OR (95%CI)a OR (95%CI)a P-trend
ATIC
rs3772078 415 583 201 279 1.0 (0.8–1.3) 20 30 0.9 (0.5–1.7) 0.98 1.0 (0.8–1.2) 0.93
rs2372536 304 409 279 399 1.0 (0.8–1.2) 67 103 0.9 (0.6–1.3) 0.76 0.9 (0.8–1.1) 0.46
rs1880586 167 245 336 473 1.0 (0.8–1.3) 149 201 1.1 (0.8–1.4) 0.88 1.0 (0.9–1.2) 0.61
rs1983462 319 417 275 417 0.9 (0.7–1.1) 60 86 0.9 (0.6–1.3) 0.42 0.9 (0.8–1.1) 0.30
rs16853826 497 696 150 210 1.0 (0.8–1.3) 8 14 0.8 (0.3–2.0) 0.93 1.0 (0.8–1.2) 0.84
rs7586969 259 348 301 436 0.9 (0.7–1.1) 93 134 0.9 (0.7–1.3) 0.76 1.0 (0.8–1.1) 0.55
rs16853834 442 657 187 241 1.1 (0.9–1.4) 26 22 1.7 (0.9–3.1) 0.13 1.2 (1.0–1.4) 0.06
rs1404772 568 807 84 108 1.1 (0.8–1.5) 3 4 1.1 (0.2–5.0) 0.86 1.1 (0.8–1.4) 0.59
rs7604984 242 332 317 442 1.0 (0.8–1.2) 96 144 0.9 (0.7–1.2) 0.84 1.0 (0.8–1.1) 0.64
SHMT2
rs7301155 121 187 153 202 1.2 (0.9–1.6) 37 49 1.2 (0.7–1.9) 0.56 1.1 (0.9–1.4) 0.33
rs2229716 601 838 51 79 0.9 (0.6–1.3) 2 1 2.4 (0.2–27.0) 0.63 0.9 (0.7–1.3) 0.70
SLC46A1
rs9894260 531 768 111 148 1.1 (0.8–1.4) 9 3 5.4 (1.4–20.5) 0.04 1.2 (0.9–1.5) 0.14
rs739439 435 610 191 283 0.9 (0.8–1.2) 26 27 1.3 (0.8–2.3) 0.48 1.0 (0.8–1.2) 0.87
rs2239908 197 270 324 473 0.9 (0.7–1.2) 131 175 1.0 (0.8–1.4) 0.76 1.0 (0.9–1.2) 0.99
rs17719944 534 753 113 157 1.0 (0.8–1.3) 7 9 1.1 (0.4–3.1) 0.96 1.0 (0.8–1.3) 0.81

aAdjusted for age (<40, 40–49, 50–59, 60–69, and 70+ years) and region of residence (Minnesota, Iowa, Wisconsin, Illinois, North Dakota, South Dakota, and North Carolina).